Cargando…

Global implementation of PrEP for HIV prevention: setting expectations for impact

INTRODUCTION: Questions remain whether HIV pre‐exposure prophylaxis (PrEP) can be translated into a successful public health intervention, leading to a decrease in population‐level HIV incidence. We use examples from HIV treatment and contraceptives to discuss expectations for PrEP uptake, adherence...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyra, Maria N, Haberer, Jessica E, Hasen, Nina, Reed, Jason, Mugo, Nelly R, Baeten, Jared M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712462/
https://www.ncbi.nlm.nih.gov/pubmed/31456348
http://dx.doi.org/10.1002/jia2.25370
_version_ 1783446685678043136
author Pyra, Maria N
Haberer, Jessica E
Hasen, Nina
Reed, Jason
Mugo, Nelly R
Baeten, Jared M
author_facet Pyra, Maria N
Haberer, Jessica E
Hasen, Nina
Reed, Jason
Mugo, Nelly R
Baeten, Jared M
author_sort Pyra, Maria N
collection PubMed
description INTRODUCTION: Questions remain whether HIV pre‐exposure prophylaxis (PrEP) can be translated into a successful public health intervention, leading to a decrease in population‐level HIV incidence. We use examples from HIV treatment and contraceptives to discuss expectations for PrEP uptake, adherence, and persistence and their combined impact on the epidemic. DISCUSSION: Targets for PrEP uptake must be based on the local HIV epidemic and will depend on appropriate estimates of the key populations at risk for HIV. However, there is evidence that targets, once established, can successfully be met and that uptake may increase with awareness. Messaging around adherence should include that daily adherence is the goal (except for those MSM for whom event‐driven dosing is a good fit), but perfect adherence should not be a barrier. Ideally, clients persist on PrEP for as long as they are at risk for HIV. While PrEP will be most effective when coverage is focused on high‐risk populations, normalizing rather than stigmatizing PrEP will be highly beneficial. CONCLUSIONS: While many challenges to PrEP implementation exist, we focused on the three key steps of uptake, adherence and persistence as measurable processes that can lead to improved coverage and decreased HIV incidence.
format Online
Article
Text
id pubmed-6712462
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67124622019-09-04 Global implementation of PrEP for HIV prevention: setting expectations for impact Pyra, Maria N Haberer, Jessica E Hasen, Nina Reed, Jason Mugo, Nelly R Baeten, Jared M J Int AIDS Soc Commentary INTRODUCTION: Questions remain whether HIV pre‐exposure prophylaxis (PrEP) can be translated into a successful public health intervention, leading to a decrease in population‐level HIV incidence. We use examples from HIV treatment and contraceptives to discuss expectations for PrEP uptake, adherence, and persistence and their combined impact on the epidemic. DISCUSSION: Targets for PrEP uptake must be based on the local HIV epidemic and will depend on appropriate estimates of the key populations at risk for HIV. However, there is evidence that targets, once established, can successfully be met and that uptake may increase with awareness. Messaging around adherence should include that daily adherence is the goal (except for those MSM for whom event‐driven dosing is a good fit), but perfect adherence should not be a barrier. Ideally, clients persist on PrEP for as long as they are at risk for HIV. While PrEP will be most effective when coverage is focused on high‐risk populations, normalizing rather than stigmatizing PrEP will be highly beneficial. CONCLUSIONS: While many challenges to PrEP implementation exist, we focused on the three key steps of uptake, adherence and persistence as measurable processes that can lead to improved coverage and decreased HIV incidence. John Wiley and Sons Inc. 2019-08-28 /pmc/articles/PMC6712462/ /pubmed/31456348 http://dx.doi.org/10.1002/jia2.25370 Text en © 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Pyra, Maria N
Haberer, Jessica E
Hasen, Nina
Reed, Jason
Mugo, Nelly R
Baeten, Jared M
Global implementation of PrEP for HIV prevention: setting expectations for impact
title Global implementation of PrEP for HIV prevention: setting expectations for impact
title_full Global implementation of PrEP for HIV prevention: setting expectations for impact
title_fullStr Global implementation of PrEP for HIV prevention: setting expectations for impact
title_full_unstemmed Global implementation of PrEP for HIV prevention: setting expectations for impact
title_short Global implementation of PrEP for HIV prevention: setting expectations for impact
title_sort global implementation of prep for hiv prevention: setting expectations for impact
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712462/
https://www.ncbi.nlm.nih.gov/pubmed/31456348
http://dx.doi.org/10.1002/jia2.25370
work_keys_str_mv AT pyramarian globalimplementationofprepforhivpreventionsettingexpectationsforimpact
AT habererjessicae globalimplementationofprepforhivpreventionsettingexpectationsforimpact
AT hasennina globalimplementationofprepforhivpreventionsettingexpectationsforimpact
AT reedjason globalimplementationofprepforhivpreventionsettingexpectationsforimpact
AT mugonellyr globalimplementationofprepforhivpreventionsettingexpectationsforimpact
AT baetenjaredm globalimplementationofprepforhivpreventionsettingexpectationsforimpact